The Team
Joel B. Braunstein, MD, MBA
Founder, Chief Executive Officer
Dr. Braunstein co-founded LifeTech Research (LTR) in 2003. In addition to guiding LTR’s vision and strategy, he provides strong analytics in the areas of clinical trial design and methods, biostatistics, outcomes research, and healthcare policy and economics. Dr. Braunstein is a board-certified cardiologist and internist who also holds an Adjunct Assistant Professorship position at the Yale School of Medicine and the Yale Center for Outcomes Research and Evaluation.
In addition to his role at LTR, Dr. Braunstein is the founding CEO and Chairman of Centegen, Inc, a private stage biotechnology company developing novel therapeutics to fight serious drug-resistant bacterial infections. He also serves as an advisor to various other private-stage life sciences companies. Dr. Braunstein has provided expert consultative services to the Coverage Policy Group of CMS (Medicare), and assisted with the development of a number of demonstration projects incorporated into the Medicare Prescription Drug, Improvement and Modernization Act of 2003. He has authored more than 80 manuscripts for peer-reviewed literature and the popular press; and also served as an editor and peer-reviewer for numerous prominent medical journals.
Dr. Braunstein received his MD from Northwestern University Medical School, where he graduated a member of the honorary medical society, Alpha Omega Alpha, and earned numerous highest distinction awards for clinical achievement. From 1996-1999, he trained in internal medicine at the Brigham and Women’s Hospital and Harvard Medical School. Between 1999-2003, Dr. Braunstein completed a cardiovascular medicine fellowship and served as a Robert Wood Johnson National Clinical Scholar at the Johns Hopkins Medical Institutions. Additionally he completed an MBA with health care management focus at the same institution.